Ambys Medicines
Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
11
51 to 200 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 6 verified contacts at Ambys Medicines
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
Showing 1 of 6 verified contacts
Top roles at Ambys Medicines
6 distinct titles indexed · top 6 shown.
- 1,,, - (-)
- 1argo
- 1bioinformatician
- 1lead animal technician
- 1sr qc associate ii, microbiology
- 1vice president in vivo technical operations
Sign up to unlock all 6 contacts at Ambys Medicines
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Ambys Medicines
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.